Samrat Pharmachem Ltd - Share Price

Open

118.40

Prev. Close

114.00

Turnover (lac.)

1

Day's High

118.40

Day's Low

113.50

52 Week's High

144.00

52 Week's Low

47.10

Book Value

79

Face Value

10

Mkt Cap (Cr.)

36

P/E

11.12

EPS

10.25

Divi. Yield

0

Samrat Pharmachem LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Samrat Pharmachem LtdNews & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd507.5040.71121,310.38531.950.792,878.64101.68
Dr Reddys Laboratories Ltd5,260.7025.3184,522.99950.200.493,244.40919.75
Divis Laboratories Ltd3,055.0050.8081,161.71492.250.521,709.96275.61
Cipla Ltd780.7527.5161,463.07610.300.523,035.72215.83
Biocon Ltd451.70155.5854,702.0084.800.00520.7062.80

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Samrat Pharmachem LtdSummary & Reports

Samrat Pharmachem Ltd is planning to de-merge its Second Unit in favour of newly formed company viz. Samrat Remedies Ltd w.e.f. April 1, 2004.... More

Registered Office

Plot No A2/3445,GIDC Phase IV,Ankleshwar, Gujarat,393002

Tell. : +91-2646-220774
Website : http://www.samratpharmachem.com
Email : samrat@bom4.vsnl.net.in

Registrar Office

C-13 Pannalal Silk, Bhandup West, Mumbai - 400 078 INDIA

Tell. : +91-022-25963838
Website : www.linkintime.com
Email : rnt.helpdesk@linkintime.co.in/mumbai@linkintime.co.in

Latest Release by samrat-pharmachem-ltd

View

- <

Reco. Price

Target Price

Target Returns:

0.00%

Result Express

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    14 Sep 2020

    Annc. Date

    31 Aug 2020

    SAMRAT PHARMACHEM LTD.-$has informed BSE that the meeting of the Board of Directors of the Company i... More

  • Purpose

    Board Meeting

    Exp. Date

    31 Jul 2020

    Annc. Date

    15 Jul 2020

    SAMRAT PHARMACHEM LTD.-$has informed BSE that the meeting of the Board of Directors of the Company i... More